Botulinum toxin type A therapy for blepharospasm-Reference-Cited by-同舟云学术

Botulinum toxin type A therapy for blepharospasm

Published:2020-11-19 Issue:11 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Duarte Gonçalo S¹²,Rodrigues Filipe B¹²,Marques Raquel E²³,Castelão Mafalda¹²,Ferreira Joaquim¹²,Sampaio Cristina⁴,Moore Austen P⁵,Costa João¹²

Affiliation:

1. Laboratory of Clinical Pharmacology and Therapeutics; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal

2. Instituto de Medicina Molecular João Lobo Antunes; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal

3. Ophthalmology University Clinic; Faculdade de Medicina da Universidade de Lisboa; Lisboa Portugal

4. CHDI Foundation; Princeton NJ USA

5. The Walton Centre NHS Foundation Trust; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference106 articles.

1. IncobotulinumtoxinA (NT-201) injections are safe and effective in adult subjects with blepharospasm across dosing intervals in a repeated dose-study;Brodsky;Movement Disorders,2011

2. Long-term treatment of blepharospasm and cervical dystonia: Incobotulinum toxin A is well tolerated when injected at flexible intervals based on patient needs;Fernandez;Journal of the Neurological Sciences,2013

3. Efficacy and safety of NT 201 (botulinum neurotoxin type A free from complexing proteins) for the treatment of blepharospasm: results of a double-blind, placebo-controlled, randomized, multicenter trial;Grafe;Physical Medicine and Rehabilitation,2010

4. Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm - a randomized trial;Jankovic;Movement Disorders,2011

5. Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm;Truong;Journal of Neural Transmission,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 12-year effectiveness and safety of botulinum toxin type A for the treatment of blepharospasm and hemifacial spasm;Revista Mexicana de Neurociencia;2024-08-22

2. Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway;Biomolecules and Biomedicine;2024-08-10

3. Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic Applications;Toxins;2024-04-03

4. Genetic Update and Treatment for Dystonia;International Journal of Molecular Sciences;2024-03-22

5. Blepharospasm: an analysis of typical medical practice and the effectiveness of therapy;Meditsinskiy sovet = Medical Council;2023-07-24